This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://digital.ahrq.gov/contact-us. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to digital.ahrq.gov for current information.

Guided medication dosing for inpatients with renal insufficiency

Authors
Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, Lee R, Mekala A, Song J, Komaroff AL, Bates DW
Journal
JAMA
Publication Date
2001 Dec 12
Volume
286
Issue
22
Pages
2839-44
  • HIT Description: Computerized decision support system in addition to computerized order entry. More info...
  • Purpose of Study: To assess whether a computerized decision support system improves drug prescribing and patient outcomes in patients with renal insufficiency.
  • Years of study: 1997-1998
  • Study Design: Controlled trial with alternating eight-week blocks of intervention and control periods.
  • Outcomes: Utilization of services and costs
Summary:
  • Settings: Large urban academic hospital with 720 beds.
  • Intervention: Computer application that ran on the existing Brigham Integrated Computing System, and which detected the presence of renal insufficiency when medications were ordered, and made suggestions regarding medications, dose amount, and frequency of administration.
  • Evaluation Method: Assessment of utilization of drugs, length of stay, and costs.
  • Description: Brigham Integrated Computing System, which provides administrative and clinical computing services at the Brigham and Women's Hospitals. This order entry application provides the physician with a range of possible dose amounts for that medication. The clinicians also offered a highlighted frequency as the recommend dosing interval.
  • Interoperability: Nearly all laboratory, radiology, and pathology results, admissions, vital signs, and demographic information can be accessed.
  • Healthcare Utilization: Adjusted mean length of stay decreased from 4.5 to 4.3 days during the intervention period.
  • Quality of Care and Patient Safety Outcome: During the intervention period the frequency of appropriate orders was 51% compared to 30% in the control, and 67% compared to 54% for orders involving dose changes, and 59% compared to 35% for orders involving frequency changes.
  • Changes in healthcare costs: No significant differences in adjusted mean total or pharmacy costs between the intervention control periods.
The information on this page is archived and provided for reference purposes only.